Skip to main content

Research Repository

Advanced Search

Economic evaluation of dialysis and comprehensive conservative care for chronic kidney disease using the ICECAP-O and EQ-5D-5L; a comparison of evaluation instruments

Zahirian Moghadam, Telma; Powell, Jane; Sharghi, Afshan; Zandian, Hamed

Economic evaluation of dialysis and comprehensive conservative care for chronic kidney disease using the ICECAP-O and EQ-5D-5L; a comparison of evaluation instruments Thumbnail


Authors

Telma Zahirian Moghadam

Profile Image

Jane Powell Jane.Powell@uwe.ac.uk
Professor in Public Health Economics

Afshan Sharghi

Hamed Zandian



Abstract

Background: Chronic Kidney Disease (CKD) patients often require long-term care, and while Hemodialysis (HD) is the standard treatment, Comprehensive Conservative Care (CCC) is gaining popularity as an alternative. Economic evaluations comparing their cost-effectiveness are crucial. This study aims to perform a cost-utility analysis comparing HD and CCC using the EQ-5D-5L and ICECAP-O instruments to assessing healthcare interventions in CKD patients. Methods: This short-term economic evaluation involved 183 participants (105 HD, 76 CCC) and collected data on demographics, comorbidities, laboratory results, treatment costs, and HRQoL measured by ICECAP-O and EQ-5D-5L. Incremental Cost-Effectiveness Ratios (ICERs) and Net Monetary Benefit (NMB) were calculated separately for each instrument, and Probabilistic Sensitivity Analysis (PSA) assessed uncertainty. Results: CCC demonstrated significantly lower costs (mean difference $8,544.52) compared to HD. Both EQ-5D-5L and ICECAP-O indicated higher Quality-Adjusted Life Years (QALYs) for both groups, but the difference was not statistically significant (p > 0.05). CCC dominated HD in terms of HRQoL measures, with ICERs of -$141,742.67 (EQ-5D-5L) and -$4,272.26 (ICECAP-O). NMB was positive for CCC and negative for HD, highlighting its economic feasibility. Conclusion: CCC proves a preferable and more cost-effective treatment option than HD for CKD patients aged 65 and above, regardless of the quality-of-life measure used for QALY calculations. Both EQ-5D-5L and ICECAP-O showed similar results in cost-utility analysis.

Citation

Zahirian Moghadam, T., Powell, J., Sharghi, A., & Zandian, H. (2023). Economic evaluation of dialysis and comprehensive conservative care for chronic kidney disease using the ICECAP-O and EQ-5D-5L; a comparison of evaluation instruments. Cost Effectiveness and Resource Allocation, 21(1), Article 81. https://doi.org/10.1186/s12962-023-00491-3

Journal Article Type Article
Acceptance Date Oct 24, 2023
Online Publication Date Nov 3, 2023
Publication Date Nov 3, 2023
Deposit Date Nov 8, 2023
Publicly Available Date Nov 17, 2023
Journal Cost Effectiveness and Resource Allocation
Electronic ISSN 1478-7547
Publisher BioMed Central
Peer Reviewed Peer Reviewed
Volume 21
Issue 1
Article Number 81
DOI https://doi.org/10.1186/s12962-023-00491-3
Keywords Cost-effectiveness analysis, Dialysis, Comprehensive conservative care, Chronic kidney disease, Quality of life, Elderly
Public URL https://uwe-repository.worktribe.com/output/11416981
Additional Information Received: 29 August 2023; Accepted: 24 October 2023; First Online: 3 November 2023; : ; : This study has been approved by the ethical committee of University of Medical Sciences with the code IR.ARUMS.REC.1400.032 where they approved that all methods of this study were performed in accordance with the relevant guidelines and regulations. Informed consent was obtained from all participants before data collection.; : Not applicable.; : The authors declare that they have no competing interests.

Files

Economic evaluation of dialysis and comprehensive conservative care for chronic kidney disease using the ICECAP-O and EQ-5D-5L; a comparison of evaluation instruments (1.3 Mb)
PDF

Licence
http://creativecommons.org/licenses/by/4.0/

Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/

Copyright Statement
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.




You might also like



Downloadable Citations